Evaluation of a hydrocortisone/hydroxypropyl-β-cyclodextrin solution for ocular drug delivery

Nigel M. Davies,Guangji Wang,Ian G. Tucker
DOI: https://doi.org/10.1016/S0378-5173(97)00199-3
IF: 6.51
1997-01-01
International Journal of Pharmaceutics
Abstract:The effect of hydroxypropyl-β-cyclodextrin (HP-β-CD) on the aqueous solubility and chemical stability of hydrocortisone (HC) was investigated with an ultimate aim of formulating a stable topical ophthalmic solution of HC. The ocular bioavailability following topical administration to rabbits of the aqueous formulation of HC was then compared to that of a suspension formulation having an equivalent HC concentration. The aqueous solubility of HC was markedly increased upon addition of HP-β-CD due the formation of a soluble 1:1 inclusion complex. The apparent association constant of the HC/HP-β-CD complex determined by phase-solubility analysis was estimated to be 0.636 mM−1. The decomposition of HC in pH 7.4 phosphate buffer followed pseudo first-order kinetics having rate constants of 13.6×10−3 and 1.70×10−3 h−1, respectively, in the presence and absence of disodium edetate. Complexation with HP-β-CD increased the chemical stability of HC with the respective pseudo first-order rate constants of decomposition being reduced to 6.73×10−3 and 0.90×10−3 h−1. The ocular bioavailability following topical administration to rabbits of a tritium labelled 1% HC solution formulation of the HC/HP-β-CD complex was lower than that of a 1% suspension formulation. A significant reduction (p<0.05) of between 25 and 40% was apparent in the cornea, aqueous humour, iris and sclera.
What problem does this paper attempt to address?